The construction of TF–mRNA–miRNA network enhances understanding of the upstream and downstream regulatory pathways involved in pulmonary fibrosis, potentially leading to novel diagnostic and therapeutic strategies for IPF and other interstitial lung diseases. This evidence concerns the gene TF and idiopathic interstitial pneumonia.